Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951. [electronic resource]
Producer: 20110928Description: 221-30 p. digitalISSN:- 1573-7373
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
- Biomarkers, Tumor -- analysis
- Brain Neoplasms -- drug therapy
- Chromosome Aberrations
- Chromosomes, Artificial, Bacterial
- Combined Modality Therapy
- Comparative Genomic Hybridization
- Humans
- In Situ Hybridization, Fluorescence
- Kaplan-Meier Estimate
- Lomustine -- administration & dosage
- Male
- Middle Aged
- Multicenter Studies as Topic
- Oligodendroglioma -- drug therapy
- Procarbazine -- administration & dosage
- Prognosis
- Proportional Hazards Models
- Radiotherapy
- Retrospective Studies
- Treatment Outcome
- Vincristine -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.